Kah-Whye Peng

2PUBLICATIONS
15CO-AUTHORS
Molecular targetsNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jun 22, 2026
Phase 1 study of oncolytic virus VV1 as monotherapy or in combination with avelumab in patients with relapsed refractory solid tumors.

|Jan 09, 2024
Surface-modified measles vaccines encoding oligomeric, prefusion-stabilized SARS-CoV-2 spike glycoproteins boost neutralizing antibody responses to Omicron and historical variants, independent of measles seropositivity.

Pageof 1

Frequent Collaborators

1 joint publications

Miguel Á Muñoz-Alía

1 joint publications

Rianna Vandergaast

1 joint publications

Adolfo García-Sastre

1 joint publications

Jaime R Merchan